4//SEC Filing
INGENITO GARY 4
Accession 0001161697-25-000175
CIK 0001369568other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 5:00 PM ET
Size
14.6 KB
Accession
0001161697-25-000175
Insider Transaction Report
Form 4
INGENITO GARY
Chief Med. & Reg. Officer
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2025-05-14$4.64/sh+44,000$204,160→ 112,873 total - Sale
Common stock, par value $0.001 per share
2025-05-14$23.63/sh−44,000$1,039,720→ 68,873 total - Exercise/Conversion
Options to purchase common stock
2025-05-13−200,000→ 590,282 totalExercise: $3.42Exp: 2027-12-30→ Common Stock (200,000 underlying) - Exercise/Conversion
Options to purchase common stock
2025-05-14−44,000→ 546,282 totalExercise: $4.64Exp: 2026-12-02→ Common Stock (44,000 underlying) - Exercise/Conversion
Common stock, par value $0.001 per share
2025-05-13$3.42/sh+200,000$684,000→ 268,873 total - Sale
Common stock, par value $0.001 per share
2025-05-13$23.68/sh−200,000$4,736,000→ 68,873 total
Footnotes (5)
- [F1]Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
- [F2]Represents a weighted average price for the shares sold. Shares were sold in a range between $23.325 and $23.93 per share.
- [F3]Represents a weighted average price for the shares sold. Shares were sold in a range between $23.44 and $24.025 per share.
- [F4]Options vested in three annual tranches beginning on December 30, 2021.
- [F5]Options vested in three annual tranches beginning on December 2, 2020.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001279473
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 5:00 PM ET
- Size
- 14.6 KB